Likelihood of Incomplete Kidney Tumor Ablation with Radio Frequency Energy: Degree of Enhancement Matters

Aaron H. Lay, Jeremy Stewart, Noah E. Canvasser, Jeffrey A Cadeddu, Jeffrey Gahan

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Purpose: Larger size and clear cell histopathology are associated with worse outcomes for malignant renal tumors treated with radio frequency ablation. We hypothesize that greater tumor enhancement may be a risk factor for radio frequency ablation failure due to increased vascularity. Materials and Methods: A retrospective review of patients who underwent radio frequency ablation for renal tumors with contrast enhanced imaging available was performed. The change in Hounsfield units (HU) of the tumor from the noncontrast phase to the contrast enhanced arterial phase was calculated. Radio frequency ablation failure rates for biopsy confirmed malignant tumors were compared using the chi-squared test. Multivariate logistic analysis was performed to assess predictive variables for radio frequency ablation failure. Disease-free survival was calculated using Kaplan-Meier analysis. Results: A total of 99 patients with biopsy confirmed malignant renal tumors and contrast enhanced imaging were identified. The incomplete ablation rate was significantly lower for tumors with enhancement less than 60 vs 60 HU or greater (0.0% vs 14.6%, p=0.005). On multivariate logistic regression analysis tumor enhancement 60 HU or greater (OR 1.14, p=0.008) remained a significant predictor of incomplete initial ablation. The 5-year disease-free survival for size less than 3 cm was 100% vs 69.2% for size 3 cm or greater (p

Original languageEnglish (US)
JournalJournal of Urology
DOIs
StateAccepted/In press - 2016

Fingerprint

Radio
Kidney
Neoplasms
Disease-Free Survival
Biopsy
Kaplan-Meier Estimate
Cell Size
Multivariate Analysis
Logistic Models
Regression Analysis

Keywords

  • Ablation techniques
  • Carcinoma, renal cell
  • Image enhancement
  • Radiation

ASJC Scopus subject areas

  • Urology

Cite this

Likelihood of Incomplete Kidney Tumor Ablation with Radio Frequency Energy : Degree of Enhancement Matters. / Lay, Aaron H.; Stewart, Jeremy; Canvasser, Noah E.; Cadeddu, Jeffrey A; Gahan, Jeffrey.

In: Journal of Urology, 2016.

Research output: Contribution to journalArticle

@article{f77c6f7caa724b37a76d7498fc75d0bb,
title = "Likelihood of Incomplete Kidney Tumor Ablation with Radio Frequency Energy: Degree of Enhancement Matters",
abstract = "Purpose: Larger size and clear cell histopathology are associated with worse outcomes for malignant renal tumors treated with radio frequency ablation. We hypothesize that greater tumor enhancement may be a risk factor for radio frequency ablation failure due to increased vascularity. Materials and Methods: A retrospective review of patients who underwent radio frequency ablation for renal tumors with contrast enhanced imaging available was performed. The change in Hounsfield units (HU) of the tumor from the noncontrast phase to the contrast enhanced arterial phase was calculated. Radio frequency ablation failure rates for biopsy confirmed malignant tumors were compared using the chi-squared test. Multivariate logistic analysis was performed to assess predictive variables for radio frequency ablation failure. Disease-free survival was calculated using Kaplan-Meier analysis. Results: A total of 99 patients with biopsy confirmed malignant renal tumors and contrast enhanced imaging were identified. The incomplete ablation rate was significantly lower for tumors with enhancement less than 60 vs 60 HU or greater (0.0{\%} vs 14.6{\%}, p=0.005). On multivariate logistic regression analysis tumor enhancement 60 HU or greater (OR 1.14, p=0.008) remained a significant predictor of incomplete initial ablation. The 5-year disease-free survival for size less than 3 cm was 100{\%} vs 69.2{\%} for size 3 cm or greater (p",
keywords = "Ablation techniques, Carcinoma, renal cell, Image enhancement, Radiation",
author = "Lay, {Aaron H.} and Jeremy Stewart and Canvasser, {Noah E.} and Cadeddu, {Jeffrey A} and Jeffrey Gahan",
year = "2016",
doi = "10.1016/j.juro.2016.01.099",
language = "English (US)",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Likelihood of Incomplete Kidney Tumor Ablation with Radio Frequency Energy

T2 - Degree of Enhancement Matters

AU - Lay, Aaron H.

AU - Stewart, Jeremy

AU - Canvasser, Noah E.

AU - Cadeddu, Jeffrey A

AU - Gahan, Jeffrey

PY - 2016

Y1 - 2016

N2 - Purpose: Larger size and clear cell histopathology are associated with worse outcomes for malignant renal tumors treated with radio frequency ablation. We hypothesize that greater tumor enhancement may be a risk factor for radio frequency ablation failure due to increased vascularity. Materials and Methods: A retrospective review of patients who underwent radio frequency ablation for renal tumors with contrast enhanced imaging available was performed. The change in Hounsfield units (HU) of the tumor from the noncontrast phase to the contrast enhanced arterial phase was calculated. Radio frequency ablation failure rates for biopsy confirmed malignant tumors were compared using the chi-squared test. Multivariate logistic analysis was performed to assess predictive variables for radio frequency ablation failure. Disease-free survival was calculated using Kaplan-Meier analysis. Results: A total of 99 patients with biopsy confirmed malignant renal tumors and contrast enhanced imaging were identified. The incomplete ablation rate was significantly lower for tumors with enhancement less than 60 vs 60 HU or greater (0.0% vs 14.6%, p=0.005). On multivariate logistic regression analysis tumor enhancement 60 HU or greater (OR 1.14, p=0.008) remained a significant predictor of incomplete initial ablation. The 5-year disease-free survival for size less than 3 cm was 100% vs 69.2% for size 3 cm or greater (p

AB - Purpose: Larger size and clear cell histopathology are associated with worse outcomes for malignant renal tumors treated with radio frequency ablation. We hypothesize that greater tumor enhancement may be a risk factor for radio frequency ablation failure due to increased vascularity. Materials and Methods: A retrospective review of patients who underwent radio frequency ablation for renal tumors with contrast enhanced imaging available was performed. The change in Hounsfield units (HU) of the tumor from the noncontrast phase to the contrast enhanced arterial phase was calculated. Radio frequency ablation failure rates for biopsy confirmed malignant tumors were compared using the chi-squared test. Multivariate logistic analysis was performed to assess predictive variables for radio frequency ablation failure. Disease-free survival was calculated using Kaplan-Meier analysis. Results: A total of 99 patients with biopsy confirmed malignant renal tumors and contrast enhanced imaging were identified. The incomplete ablation rate was significantly lower for tumors with enhancement less than 60 vs 60 HU or greater (0.0% vs 14.6%, p=0.005). On multivariate logistic regression analysis tumor enhancement 60 HU or greater (OR 1.14, p=0.008) remained a significant predictor of incomplete initial ablation. The 5-year disease-free survival for size less than 3 cm was 100% vs 69.2% for size 3 cm or greater (p

KW - Ablation techniques

KW - Carcinoma, renal cell

KW - Image enhancement

KW - Radiation

UR - http://www.scopus.com/inward/record.url?scp=84969523602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969523602&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2016.01.099

DO - 10.1016/j.juro.2016.01.099

M3 - Article

C2 - 26826583

AN - SCOPUS:84969523602

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

ER -